Results of The Population PK Modelling of RTXMB83, A Rituximab Biosimilar Candidate in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI